{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:57:21Z","timestamp":1790236641473,"version":"4.1.0"},"reference-count":97,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Exp Med"],"abstract":"<jats:p>Cardiac amyloidosis (CA) is a progressive infiltrative cardiomyopathy resulting from the deposition of misfolded amyloid fibrils in the myocardium and heart valves, with the main forms being amyloid light-chain (AL), transthyretin-related (ATTR) (wild-type or hereditary), and amyloid A amyloidosis. Although historically underdiagnosed, recent advances in non-invasive imaging techniques such as cardiac magnetic resonance imaging and bone scintigraphy have significantly improved its recognition. This review outlines the current diagnostic approaches and therapeutic advancements in CA, emphasizing a multimodal strategy that includes imaging, cardiac biomarkers, and tissue biopsy with precise amyloid subtyping. Diagnosis remains challenging and requires a high degree of clinical suspicion, as delayed recognition can lead to rapid clinical deterioration. Clear diagnostic algorithms and a multidisciplinary care model are essential to improving outcomes. AL amyloidosis is primarily managed with chemotherapy and, when appropriate, stem cell transplantation, while tafamidis is currently the only approved treatment for ATTR amyloidosis, though new therapeutic agents are in development. Overall, recent progress in diagnosis and treatment has enhanced patient outcomes, and early detection combined with coordinated care is key to managing this complex condition.<\/jats:p>","DOI":"10.5493\/wjem.v16.i1.112270","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:30:26Z","timestamp":1773462626000},"source":"Crossref","is-referenced-by-count":2,"title":["Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs"],"prefix":"10.5493","volume":"16","author":[{"given":"Maha","family":"Bouziane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Moufid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachida","family":"Habbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000506696"},{"key":"B2","unstructured":"Papingiotis G, Basmpana L, Farmakis D. Diagnosis and therapy of cardiac amyloidosis: epidemiology, diagnosis and therapy.  E J Cardiol Pract 2021; 19-21"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5543\/tkda.2019.28035"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2021.04.023"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10162-1"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.596"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx043"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.003"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02962-5"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz173"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2012.674074"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.231"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s44263-023-00016-3"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature02261"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318187"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1006\/jsbi.2000.4248"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.053"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2023.02.006"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.05.097"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2533"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab072"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/pace.14023"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-018-1146-9"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01781-z"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14040407"},{"key":"B27","unstructured":"Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol 1979; 284-293"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2015.1122687"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2016.07.001"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4013-4"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew325"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.02.030"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-019-0584-8"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113446"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05144-8"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01799-3"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4103\/0971-6203.25665"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-015-0338-0"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302548"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-018-1365-x"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.04.010"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.07.56"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068314.02595.B2"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2769"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.117143"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.029"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0480"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-290668"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.022"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.07.022"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100720"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0952-8"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-0298-9_138"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2017.1304649"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2549-y"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3109\/13506120903421850"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-022-10247-5"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2020.12.047"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2022.08.005"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2011.10.001"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2017.10.012"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.102764"},{"key":"B66","doi-asserted-by":"crossref","unstructured":"Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med 1983; 1549-1552","DOI":"10.1001\/archinte.1983.00350080055015"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.126"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01274-X"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101188"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000792"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.078915"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12749"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90996-8"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2023.02.004"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf085.152"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2024.12.032"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01285"},{"key":"B79","unstructured":"Stichting European Myeloma Network.   A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis. [cited 2022 Jan 31]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04131309 ClinicalTrials.gov Identifier: NCT04131309"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew298"},{"key":"B81","unstructured":"Martinez-Naharro A, Abdel-Gadir A, Treibel TA, Zumbo G, Knight DS, Rosmini S, Lane T, Mahmood S, Sachchithanantham S, Whelan CJ, Lachmann HJ, Wechalekar AD, Kellman P, Gillmore JD, Moon JC, Hawkins PN, Fontana M. Abstract 14407: Regression of Cardiac AL Amyloid by Cardiovascular Magnetic Resonance. Circulation 2016; A14407"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/13506120600960882"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2012.00303.x"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004769"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2014.997872"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2019.1593133"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2017.1301419"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2300757"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409134"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-74"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2012.678508"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2016.1269739"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2019.01.006"},{"key":"B95","unstructured":"Fondazione IRCCS Policlinico San Matteo di Pavia.   A Study of Doxycycline and Tauroursodeoxycholic Acid (Doxy\/TUDCA) Plus Standard Supportive Therapy Versus Standard Supportive Therapy Alone in Cardiac Amyloidosis Caused by Transthyretin. [cited 7 November 2025]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03481972 ClinicalTrials.gov Identifier: NCT03481972"},{"key":"B96","unstructured":"Neurimmune AG.   First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy. [cited 7 November 2025]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): U.S. National Library of Medicine. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04360434 ClinicalTrials.gov Identifier: NCT04360434"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1299261"}],"container-title":["World Journal of Experimental Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2220-315X\/full\/v16\/i1\/112270.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2220-315X\/full\/v16\/i1\/112270.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:31:03Z","timestamp":1773462663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2220-315X\/full\/v16\/i1\/112270.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":97,"journal-issue":{"issue":"1"},"alternative-id":["112270"],"URL":"https:\/\/doi.org\/10.5493\/wjem.v16.i1.112270","relation":{},"ISSN":["2220-315X"],"issn-type":[{"value":"2220-315X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}